Skip to content

HEMOREINE suppositoires

by FARMA-DERMA S.r.l. Italy EUDAMED

Ref 2011 EMDN G05

Regulatory status

as of 26 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/MDR Number803259587TF02ED Basic UDI-DIDate4 Aug 2023RegisteredStatusWithdrawn Not intended for the EU market

Coverage

1 jurisdiction

SwedenFinlandFinlandSwedenFinlandFinlandSwedenSwedenLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyGermanyPolandPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaPolandFranceFranceAustriaHungaryRomaniaFranceFranceSloveniaBulgariaPortugalSpainSpainItalySpainSpainCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not known
  • Not covered

European Union — CE/MDR Withdrawn

Certificates

1 certificate · EUDAMED

EUDAMED certificates (1)
  • EPT 0477.MDR.22/5022 Issued

    Quality management system EU MDR

    Notified body
    Notified body 0477
    Issued
    20 Dec 2022
    Expires
    19 Dec 2027

Specification

EUDAMED · synced 25 Oct 2026

Device Name
Cicatridina supposte
Model / Reference
2011
Primary DI / UDI-DI
08032595871569
Basic UDI-DI
803259587TF02ED
EMDN Code
G05 Topical anorectal administered gastro-intestinal system devices
Device Class
Class IIb

Manufacturer details

EUDAMED SRN
IT-MF-000020737

Other devices from FARMA-DERMA S.r.l.

See all devices from FARMA-DERMA S.r.l. →

Properties & raw data

Show properties, registry sources and raw records
Other properties (13)
  • Sterile: No
  • Implantable: No
  • Reusable: No
  • Contains Latex: No
  • Reprocessed: No
  • CMR Substance: No
  • Human-derived: No
  • Human Tissues: No
  • Animal Tissues: No
  • Endocrine Disruptor: No
  • Administering Medicine: No
  • Measuring Function: No
  • Incorporates Medicinal Product: No

Sources (1)

  • EUDAMED 52366906-41c3-449e-b450-32210ca88647 61 fields · synced 25 Oct 2026